Top search results

When you're taking different drugs together, it could change how well they work or the side effects they have. It's important to tell your doctor or pharmacist about all the medications you are taking.

At CROI 2024, Dr Aadia Rana from the University of Alabama at Birmingham spoke to aidsmap's Roger Pebody about injectable treatment for people with adherence challenges.

An animation on how to take HIV medication.

An animation on side effects that you might experience with HIV medication.

An animation describing how HIV medication works.

At CROI 2024, Dr George Bello from the Malawian International Training and Education Center for Health spoke to aidsmap's Roger Pebody about dolutegravir resistance in Malawi.

At CROI 2024, Professor Nicholas Paton from the London School of Hygiene and Tropical Medicine spoke to aidsmap's Roger Pebody about injectable HIV treatment in Africa.

At CROI 2024, Dr Amy Colson from the Community Resource Initiative in Boston spoke to aidsmap's Roger Pebody about islatravir and lenacapavir as a once-weekly oral HIV treatment.

At EACS 2023, Dr Luis Sagaon-Teyssier from Institut de Recherche pour le Développement spoke to NAM aidsmap's Roger Pebody about drug-reduced strategies at one of Paris's largest HIV clinics.

With activist Mercy Shibemba; Communications Director at UNAIDS, Ben Phillips; 'London patient' Adam Castillejo; HIV consultant Dr Laura Waters; and writer Gus Cairns. 

At IAS 2023, Dr Andrew Hill from the University of Liverpool talks to NAM aidsmap's Roger Pebody about adherence counselling reversing viral rebound on dolutegravir.

At IAS 2023, Dr Asier Sáez-Cirión from the Institut Pasteur spoke to NAM aidsmap's Roger Pebody about HIV remission after a stem cell transplant. 

 At CROI 2023, Professor Joseph Eron from University of North Carolina spoke to NAM's Roger Pebody about lenacapavir and two broadly neutralising antibodies for treatment.

Starting anti-HIV treatment improves your health, suppresses HIV and helps to strengthen your immune system. But treatment can also cause side effects, including weight gain.

At HIV Glasgow 2022, Professor Chloe Orkin, from Queen Mary University London, spoke to Roger Pebody about who is at risk of injectable treatment failure.

'Adherence' means taking your HIV medication in the right way, at the right time. Matthew Hodson, Susan Cole and Mercy Shibemba share some things you can do to help you take your medication properly.

At AIDS 2022, Dr Jana Dickter talks about the 'City of Hope patient', a man from California who appears to have been cured of HIV after a stem cell transplant.

At AIDS 2022, Dr Núria Climent & Dr José Alcamí from Hospital Clínic de Barcelona talk about a woman in Barcelona who has maintained an undetectable HIV viral load for more than 15 years after stopping antiretroviral therapy.

With Dr Shema Tariq, researcher and HIV consultant at University College London and Mortimer Market Centre; Joshua Wharton from George House Trust; Angelina Namiba from the 4M Network; long-term HIV survivor and campaigner George Hodson; and Dr Charles Mazhude, consultant HIV/genitourinary physician at University Hospital Lewisham.

Fungai Murau talks to Susan Cole about weight gain in women with HIV in this video we've produced with the Sophia Forum, Positively UK and UCL Institute for Global Health.

With Dr Tristan Barber, HIV doctor at The Royal Free Hospital with expertise in ageing issues; Jo Josh, communications adviser at the British HIV Association; Rebecca Mbewe, co-director of the 4M Mentor Mothers Network; and campaigner Richard Desmond, who has been living with HIV since 1985.

Dr Roger Shapiro from Harvard University talks about antibody treatment for children with HIV and could it be used instead of pills at CROI 2022.

At CROI 2022, Professor Yvonne Bryson from the University of California Los Angeles talks about the woman in New York who has no detectable HIV 14 months after stopping antiretroviral therapy following a stem-cell transplant for leukaemia.

People living with HIV are living increasingly long lives. NAM aidsmap's Susan Cole talks about life expectancy for people living with HIV in our video.

Elena Vovc from the World Health Organization talks about the COVID-19 pandemic and how it has impacted HIV diagnoses, treatment and prevention. Elena presented these findings at a session at the EACS 2021 conference.

At IAS 2021, Dr Maggie Czarnogorski of ViiV Healthcare talks about providing injectable HIV treatment.

With Director of Global HIV, Hepatitis and STI Programmes at the World Health Organization, Dr Meg Doherty; Chair of the British HIV Association, Dr Laura Waters; National Co-ordinator of the Kenya Sex Workers Alliance, Phelister Abdalla; and IAS 2021 rapporteur and Chief Medical Information Officer at the University Hospital Rechts der Isar, Germany, Dr Christoph Spinner.

Professor Jean-Michel Molina of Hôpital Saint-Louis in Paris talks about injectable lenacapavir, a capsid inhibitor currently under development, for people with multidrug-resistant HIV at IAS 2021.

At IAS 2021, Professor Samir Gupta of Indiana University talks about lenacapavir, an experimental capsid inhibitor, for people starting HIV treatment.

With writer and activist, Bob Leahy; trans writer and campaigner, Juno Roche; HIV advocate and treatment rights campaigner, Winnie Ssanyu Sseruma; HIV doctor at The Royal Free Hospital with expertise in ageing issues, Dr Tristan Barber; and NAM's Executive Director, Matthew Hodson.

With Chair of the British HIV Association, Dr Laura Waters; Deputy Director of the Desmond Tutu HIV Centre, Professor Linda-Gail Bekker; AIDS 2020 plenary speaker and Positive Young Women Voices team leader, Lucy Wanjiku Njenga; and NAM aidsmap Editor, Gus Cairns.

According to a report presented at the AIDS 2020 conference, a man in São Paulo had no evidence of remaining HIV after more than 15 months off antiretrovirals. Dr Andrea Savarino from the Instituto Superiore di Sanita in Rome talks to NAM aidsmap.

With House Of Rainbow founding Pastor, Rev Jide Macaulay; HIV activist and actor, Jonathan Blake; HIV consultant and researcher, Dr Steve Taylor; youth HIV advocate, Becky Kroger; trans activist, Rebecca De Havilland; and NAM aidsmap's Executive Director, Matthew Hodson.

With British HIV Association secretary and HIV consultant, Dr Laura Waters; activist and founder of iwantPrEPnow, Greg Owen; HIV advocate and Salamander Trust Associate, Angelina Namiba; HIV activist and advocate, Mercy Ngulube; founder of cliniQ, Michelle Ross; and NAM aidsmap's Executive Director, Matthew Hodson.

Our HIV Community Forum shared information on HIV treatment and prevention from the 9th IAS Conference on HIV Science. With Dr Tristan Barber, from Chelsea and Westminster NHS Foundation Trust; Memory Sachikonye, from UK Community Advisory Board (UK-CAB); and Gus Cairns and Roger Pebody, from NAM aidsmap.